Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Temodar

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCGI1250

    04/09/2013

    A Phase I/II Study of the Combination of Temozolomide and Pazopanib in Advanced Pancreatic Neuroendocrine Tumors (PNET)


    Print this page for your doctor